Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Samrat Pharmachem has informed that it submitting the summary of the proceedings of the 30th Annual General Meeting (AGM) of the members of the Company held on Friday, September 30, 2022 at 2.00 pm (IST) through Video Conferencing ('VC')/ Other Audio-Visual Means ('OAVM') conducted by NSDL. Further pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has submitted the details regarding the voting results of the business transacted at the AGM in the prescribed format. The business mentioned in the Notice dated May 30, 2022 was transacted. The Company has also enclosed the consolidated report of the Scrutinizer on e-voting and e-voting at the AGM. The above are being uploaded on the Company’s website ‘www.samratpharmachem.com’.
The above information is a part of company’s filings submitted to BSE.